Mstack launched Chemstack AI, a platform designed to reduce chemical synthesis as well as commercialisation timelines amid a widely reported supply chain crisis in the chemical sector.
With this launch of Chemstack AI, Mstack aims to address a major bottleneck in the chemical industry relating to the scarcity of specialised process chemistry knowledge for local manufacturing.
This platform is promoted as the first closed-loop AI ecosystem in chemical Research & Development, focusing on the acceleration of molecular synthesis and route commercialisation from approximately 18 months to just a matter of days.
Chemstack AI consists of three principal modules:
- The first, LitreatureIQ, structures chemical literature into knowledge graphs.
- The second, MSTACK RetroRank, is an AI tool that generates and ranks synthetic routes, reportedly achieving a 98.6% exact match recall and 72.6% Top-1 accuracy.
- The final module, Experimentation Assist, leverages Bayesian Optimisation to navigate laboratory reaction configurations, creating a feedback loop between AI modelling and laboratory outcomes.
The company claims this closed-loop architecture enables the automation and acceleration of processes that have traditionally been lengthy and reliant on manual expertise. Automation and advanced data analysis are central to the system, which aims to mimic the intuition and strategic thinking of skilled chemists.
According to Coherent Market Insights, the Pharmaceutical Fine Chemicals Market is projected to grow at a CAGR of 8.1% during 2025 to 2032. Currently, the market is at USD 136.42 Billion in 2025 and is expected to be around USD 235.32 Billion by 2032. The pharmaceutical fine chemicals market growth is witnessing steady growth, driven by increasing demand for high-purity active pharmaceutical ingredients (APIs) and intermediates used in drug manufacturing.
"We're not just another chemical company-we're fundamentally redefining what's possible when AI becomes the world's smartest chemist. Our 10x growth trajectory demonstrates that the market desperately needs innovation-driven supply diversification, and traditional players simply can't innovate synthesis routes at the speed and scale necessary to create viable alternatives. While others are locked into legacy processes that haven't been reimagined in decades, our AI scales knowledge across domains, enabling us to operate with the efficiency of large commodity players while maintaining the innovation agility of specialty companies," said Shreyans Chopra, Founder of Mstack.
Mstack works with major agrochemical firms, some of which are reportedly reducing their reliance on suppliers in China. Its platform also supports clients across many sectors—coatings, adhesives, sealants, elastomers (CASE), oil & gas, home & personal care, and construction chemicals.
Source:
News: Express Pharma
Company: Mstack